dose to the pancreas and certainly less than two times the dose to the

pancreas.
Now

we

previously

stated

that

we

would

evaluate

the

dose

to

the

salivary glands and the lactating breast from the ingestion of lIodine-131.
Both

of these tissues can concentrate

Stomach,

lactating

concentrating

breast,

mechanisms,

and

or

iodine.

certain

an

iodine

Serous

other

tissues

salivary glands,
possess

concentrating mechanism

iodine
that

is

comparable to that of the thyroid.
Next

viewgraph,

please

(LRA-14).

We

can

summarize

available data by examining the fluid-to-plasma ratio.
11

fluid-to-plasma

12

juice,

13

derived.

14

to a

15

rate.

16

inversely with the collection rate.

17

ratio

and milk;

and

the

range

of

values

for

the

readily

We list the average
saliva,

for

gastric

and these are the references from which the data were

In the case of the salivary glands, the fluid-to-plasma ratio are

large extent
In

the

independent of the plasma concentration and secretion

case

of

gastric

juice,

the

fluid-to-plasma

May I have the next viewgraph, please (LRA-15).

ratio

varies

So we made attempts

18

to estimate dose factors to extrathyroidal fodide concentrating tissues for

19

jodine-131 as follows:

20

assumed to be the rapidly turning-over component of the iodine retention

21

function

22

effective turnover rate of about two per day.

23

concentration in extracellular fluid is then 0.7, assuming that 0.7 of the

24

ingested ‘iodine

25

corresponds to the iodide space,

26

that we just examined above.

27
28

This

with

leads

a

The half-life of iodine in extracellular fluid is

half-life

goes

to

of 0.35

the

to a time

days;

extracellular

this

is equivalent to an

Now the time integral of the

fluid,

and

the

2.7 x

104 ml

and the two per day is the turnover rate

integral

cellular fluid of 1.3 x 10-5 d/1.

and

then of the concentration

in extra-

Now we assume that the equivalence of

Select target paragraph3